In the current issue of Psychotherapy and Psychosomatics, researchers failed to find evidence for the use of aripiprazole (Abilify®) in depression. In this study the investigators assessed the efficacy of low-dose aripiprazole added to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) with inadequate response to prior ADT.

Recent Comments